Miyajima Keisuke, Kobayashi Wakaba, Hakamata Shogo, Takazawa Yasukazu, Kawaguchi Yoshitaka, Wakabayashi Yasushi, Maekawa Yuichiro
Department of Cardiology, Seirei Mikatahara General Hospital, 3453 Mikatahara-cho, Kita-ward, Hamamatsu, Shizuoka 433-8558, Japan.
Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.
Eur Heart J Case Rep. 2025 Jan 15;9(1):ytae677. doi: 10.1093/ehjcr/ytae677. eCollection 2025 Jan.
Transthyretin cardiac amyloidosis is associated with various arrhythmias, including atrioventricular block. Despite this correlation, established treatments for transthyretin cardiac amyloidosis-associated arrhythmias are lacking. Left bundle branch area pacing is a promising physiological pacing technique.
This case series describes three instances of successful left bundle branch area pacing in patients with transthyretin cardiac amyloidosis presenting with atrioventricular block. Despite significant ventricular septal hypertrophy across all cases, left bundle branch area pacing was implemented effectively without complications.
Traditional pacing strategies in transthyretin cardiac amyloidosis, such as right ventricular pacing, have been associated with a reduced left ventricular ejection fraction and worsening heart failure. Although biventricular pacing has been explored, the supporting evidence remains limited and inconclusive. Recent studies have suggested that left bundle branch area pacing poses a lower risk of inducing heart failure than biventricular pacing. Our findings support the safety and efficacy of the left bundle branch area pacing in patients with transthyretin cardiac amyloidosis-related atrioventricular blocks and underscore its viability as a pacing strategy.
转甲状腺素蛋白心脏淀粉样变性与各种心律失常相关,包括房室传导阻滞。尽管存在这种相关性,但缺乏针对转甲状腺素蛋白心脏淀粉样变性相关心律失常的既定治疗方法。左束支区域起搏是一种有前景的生理性起搏技术。
本病例系列描述了3例转甲状腺素蛋白心脏淀粉样变性伴房室传导阻滞患者成功进行左束支区域起搏的情况。尽管所有病例均存在明显的室间隔肥厚,但左束支区域起搏实施有效,无并发症发生。
转甲状腺素蛋白心脏淀粉样变性的传统起搏策略,如右心室起搏,与左心室射血分数降低和心力衰竭恶化有关。尽管已经探索了双心室起搏,但其支持证据仍然有限且尚无定论。最近的研究表明,左束支区域起搏诱发心力衰竭的风险低于双心室起搏。我们的研究结果支持左束支区域起搏在转甲状腺素蛋白心脏淀粉样变性相关房室传导阻滞患者中的安全性和有效性,并强调了其作为一种起搏策略的可行性。